curriculum vitae tazeen h. jafar, mbbs; mph personal details · curriculum vitae tazeen h. jafar,...

of 24

CURRICULUM VITAE

TAZEEN H. JAFAR, MBBS; MPH Personal details: Current Professional Address: Duke-NUS Medical School Singapore Email: [email protected] Fax: (+65) 65348632 Tel: (+65) 66012582 Cell: (+65) 96588143 Education and Training: Master in Public Health Harvard School of Public Health, Boston. 1998- 2000

Diploma in Clinical Effectiveness Harvard School of Public Health, Boston. 1998

Clinical & Research Fellow in Nephrology Tufts Medical Center, Boston. Aug 1996 – Mar 2000

Residency in Medicine/Pediatrics University of Texas Health Science Center at Houston Oct 1991-

Sept 1995

MBBS Aga Khan University, Karachi Sep 1985- Nov 1990

Examination and Certification: 2010 Re-certification, American Board of Internal Medicine, subspecialty Nephrology

1999 American Board of Internal Medicine, subspecialty Nephrology

1998 Certificate course in Clinical Effectiveness at Harvard School of Public Health 1997 American Board of Internal Medicine

1995 American Board of Pediatrics

1991 ECFMG Part 1 & 2

Other Certifications: 2016: BLS

2016: ACLS

Primary Academic Position: Duke-NUS Medical School Singapore Feb 2012- Professor, Program in Health Services & Systems Research

of 24

Affiliate Academic Positions: 2000-present Adjunct faculty (Professor in 2013), William B Schwartz Division of Nephrology,

Tufts Medical Center, Boston, MA.

2012-present : Visiting faculty, Department of Medicine, Aga Khan University, Karachi

2015-present : Research Professor Global Health, Duke Global Health Institute, Durham, NC,

USA

(Past) Academic Positions: Aga Khan University, Karachi, Pakistan

June 2009- 2012 AKU Endowed Professorship, Nephrology & Community Health Sciences

Jan 2008- Professor, Nephrology, Departments of Medicine & Community Health Sciences

Jan 2004-Dec 2007 Associate Professor, Departments of Medicine (Nephrology) and

Community Health Sciences

May 2000-Dec 2003 Assistant Professor, Departments of Medicine (Nephrology) and

Community Health Sciences

(*two accelerated promotions- from Assitant Professor to Associate Professor, and then to full

professor).

Hospital Positions: 2015- Staff Consultant Nephrologist, Durham VA Medical Center, Durham, NC, USA

April 1, 2013- Visiting Consultant, Renal Medicine, Singapore General Hospital, Singapore

May 2000-2012- Consultant Nephrologist, Aga Khan University Hospital, Karachi, Pakistan

Medical Licenses:

State of Wisconsin (current)

Singapore Medical Council (Renal Medicine Specialist)- current

of 24

Past Administrative Positions: 2003-2009 Founding Chief, Section of Nephrology, Department of Medicine (established a

separate Section of Nephrology within Department of Medicine, catalyzed the approval of a

functional ambulatory dialysis unit in Aga Khan Hospital, started fellowship program in

Nephrology, and completed two full terms as Section Chief)

2002-2012 Founding Director, Clinical Epidemiology Unit (affiliate of the International Network

of Clinical Epidemiology (INCLEN)- Pakistan- based at AKU

Academic and Training Programs: 2005-2010 Founding Director, Master of Science in Clinical Research Program at Aga Khan University (completed two full terms) 2003-2009 Founding Director, Clinical Scholars’ Program (offers Diploma in Clinical Epidemiology to specialist clinicians) at Aga Khan University (completed two full terms).

Wellcome Trust, UK 2010-2013, Member, Expert panel, Wellcome Trust/DFID/MRC Global Health Trials funding committee 2006-2009 Member, Funding committee, Populations and Public Health, The Wellcome Trust, UK. UK- Medical Research Council 2014: Member grant reveiw and funding panel for diabetes research (GACD)

2015: Member grant review and funding panel for respiratory diseases (GACD)

Canadian Institutes of Health Research (CIHR) 2015, Member, Strategy for Patient-Oriented Research (SPOR) grant review panel

World Bank

of 24

May 2009 to July 2009- Consultant, Report on Chronic Non-communicable Disease Burden and

Health Systems Capacity Strengthening in South Asia Region

International Press Releases/Media coverage of Dr Jafar’s work COBRA trial results- Heartwire (theHeart.org), and several international print media 2009

• Organ Trafficking-Medscape Nephrology 2009

• GP education and hypertension control in Pakistan- Medscape and MD consult 2007 • Chronic Kidney Disease in Pakistan – Time Magazine 2006

• Chronic Kidney Disease in Pakistan – Medscape 2006

• Obesity epidemic in Pakistan- covered by international radio and print media in Canada,

and Europe in Sept 2006.

• AJKD eblog interview Sept 2013

• NCD epidemic in Pakistan-launch of Pakistan Lancet series May 2013

• Global disparities in access to dialysis (Lancet commentary)- April 2015

• Association of eating out with high blood pressure in Singapore- May 2015

• Tobacco legislation in Pakistan (Lancet Repiratory Medicine Sept 2015)

• Health Education and GP training- Long Term Effects on Kidney Function (cJASN)-

May 2015

• Redmeat intake and Risk of End Stage Kidney Disease (JASN) –July 2016

• Living Kidney Donation Safe- press release in Straitstime Dec 2016

Major Role in Organization of Conferences:

• 2016-2017- Cochair, 22nd Annual Scientific Meeting, Singapore General Hospital April

2017

• 2015-2017 Member Scientific Committee- 2017 World Congress of Nephrology annual

meeting to be held in Mexico City.

• Mar 2015- Duke-Durham-Duke-NUS HSSR Bridging Symposium on Global NCD-

focus on vascular disease

of 24

• May 2009- Lead coordinator, National Commission on Non-communicable Diseases,

Pakistan (meeting hosted by Ministry of Health in collaboration with US- Centres for

Disease Control & Prevention)

• Feb 2009- Chair Scientific Program Committee, AKU-Summit Non-communicable

Diseases, Kampala, Uganda Feb 2009

• Dec 2008- Chair Organizing Committee, 25 Year Reunion AKU Alumni (Silver Jubilee

of Medical College)

Recent & Key Invited Lectures/conferences international (select):

• Invited speaker at “Update in Nephrology” course of International Society of Nephrology at

Dubai, Nov 2004.

• Invited Chair, Symposium on Strategies for Prevention of Kidney Disease in Developing

Countries, World Congress of Nephrology, Singapore, June 2005.

• Invited speaker at “Renal Remission Clinic Workshop” Bergamo, Italy September 15 and

16th, 2006.

• Invited speaker as ASN faculty at Clinical Science Symposium on “Target Blood Pressure in

Chronic Kidney Disease” at the American Society of Nephrology meeting November 14-19,

2006 at San Diego, CA.

• Invited speaker Renal Grand Rounds at University Hospitals of Cleveland (Case Western

Reserve University), Cleveland Ohio March 27, 2007 on “Hypertension and Chronic Kidney

Disease-A Global Health Perspective”

• Invited speaker Asian Forum of CKD Initiative May 27-28, 2007 Hamamatsu, Japan.

• Wellcome Trust workshop in London on secondary prevention of cardiovascular disease in

low and middle income countries June 6-8 , 2007

• INCLEN-SEA meeting Bali Aug 25-26, 2007

• National Clinical Research Conference in Malaysia Oct 25 -26, 2007.

• Global Health Forum, Beijing, Wellcome Trust satellite meeting Oct 27-30, 2007.

• US Federal Drug Administration “Proteinuria as a Surrogate Outcome of Kidney disease” at

FDA campus Silver Spring, MD May 2008.

of 24

• Plenary session- Special Lecture “CKD- a Global Public Health Problem” World Congress of

Nephrology, Milan, Italy May 2009

• Member Planning Committee, Controversies in Chronic Kidney Disease Classification- Oct 2009 (London meeting)

• Invited Speaker- NIDDK conference on International Studies on CKD- Baltimore, Maryland,

USA. March 2010

• Renal Grand Rounds, Tufts Medical Center, Boston- March 2010.

• Plenary session- “CKD Classification-where do we go from here?” Malaysian Society of

Nephrology annual meeting April 2010

• Invited Speaker “Non-communicable Diseases in Pakistan: research to policy” Annual

Regional Meeting of International Epidemiology Association (South East Asian Chapter) Sri

Lanka, Colombo, Sri Lanka May 2010

• Renal Grand Rounds, University of Texas Health Science Center at San Antonio, March

2011

• Invited speaker, Welch Center, Johns Hopkins University, Baltimore, April 2011

• Research conference, William B Swartz Division of Nephrology, Tufts Medical Center,

Boston, MA, April 2011

• Invited Speaker, Duke National University of Singapore Graduate School May 2011

• Invited panelist, Informal Civil Society Interactive Hearing, New York, June 2011 (in

preparation for UN High Level meeting for NCD prevention & control)

• Invited speaker, Welch Center, Johns Hopkins University, Baltimore, June 2011

• Invited speaker, World Congress of Epidemiology, Edinburgh Aug 2011

• Invited Speaker 8th Asian Pacific Congress of Hypertension, Taiwan Nov 2011

• Invited speaker, the George Institute, Beijing, Nov 2011

• Invited speaker, the George Institute, Sydney, Nov 2011

• Scientific Program Committee, World Congress of Cardiology, UAE March 2012.

• Invited speaker, Asia Pacific Society of Hypertension, Dhaka, May 2012

• Invited panelist NKF-FDA workshop on GFR Decline as an Endpoint for Clinical Trials

(Baltimore, Dec 2012)

• Invited speaker, Duke Global Health Institute, Durham, April 2013

of 24

• Invited speaker, launch of Pakistan Lancet series, Federal Ministry of Health, Islamabad,

Pakistan

Invited speaker, National Symposium on Non-communicable Diseases in Paksitan Feb 2014

• Invited speaker, Asia Pacific Conference on Hypertension, Cebu, Phillipines, Feb 2014

• Invited speaker, Renal Grandrounds, University of California San Francisco, April 2014

• Invited speaker, Annual meeting Sri Lanka Medical Association, July 2014

• Invited member, KDIGO meeting on Strategies for Treatment of Diabetic Kidney Disease,

Vancouver, Canada, Feb 2015

• Invited speaker, late breaking abstracr, COBRA-post trial follow up kidney function, World

Congress of Nephrology, Cape Town, March, 2015.

• Invited panelist, AKCKDI, Jakarta, May, 2015

• Invited speaker, Symposium on Aging and CKD, American Diabetes Association Annual

Meeting, Boston, MA, June, 2015.

• Invited discussion leader and steering committee member, KDIGO meeting on

Implementation of CKD Guidelines in LMICs, Bangkok, June 2015

• Invited plenary speaker, International Symposium, Sindh Institute of Urology &

Transplantation, Karachi, Pakistan. Dec 2015

• Renal Grandrounds, Division of Nephrology, Duke University, NC, Durham, US, Feb 2016

• Invited panelist, International Congress of Renal Nutrition and Metabolism, Okinawa, Japan,

April 2016

• Invited speaker, Asia Pacific Congress of Nephrology, Perth, Australia, Sept 16-19, 2016

• Invited speaker, International Society of Hypertension meeting, Seoul, Sept 24-29, 2016

• Invited speaker, Pakistan Society of Nephrology, Islamabad, Pakistan, March 24-27, 2017

• Invited speaker, World Congress of Nephrology, Mexico City, Mexico, April 21-25, 2017

Teaching/Education/courses:

2016: 3 Journal club sessions for renal residents and fellows at Singapore General Hospital 2015: Journal club sessions for renal residents and fellows at Singapore General Hospital

2014: Short course (2 full day) on Grant and proposal writing skills at SingHealth-Duke

Conference, Singapore

of 24

2003-2010: Course Director NCD Epidemiology for Master Science in Epidemiology &

Biostatistics students, Aga Khan University

Editorial Activities:

2015-2017 Deputy Director, International Society of Nephrology Publications Committee

2013- Abstract reveiwer for kidney week 2013

2013-Associate Editor, BMC Nephrology

2010- AJKD’s World Kidney Forum, Member, Advisory Panel

2010- Public Library of Sciences, Member, International Advisory Panel

2010- Nephrology, Subject Editor for Hypertension and Epidemiology

2009- Nephron Clinical Practice, Section Editor, Nephron CPC.

2006- 2011 American Journal of Kidney Diseases, Member, Editorial Board

2007- Nephron- Member, Editorial Board.

2004- European Review for Medical and Pharmacological Sciences- Member, Editorial Board.

2003-2008- Journal of Hypertension- Member, Editorial Board.

Regular reviewer for many journals including:

Annals of Internal Medicine, Circulation, CMAJ, Journal of the American Society of

Nephrology, C-JASN, Diabetes Care, and American Journal of Hypertension.

(Rated among top tertile of reviewers for Annals of Internal Medicine in 2004 and 2006 )

Professional Society Memberships: American Society of Nephrology

American Society of Hypertension

International Society of Nephrology

Asia Pacific Society of Nephrology

International Network of Clinical Epidemiology

Research Network Memberships: Chronic Kidney Disease Prognosis Consortium (US Based sponsored by NKF)

South Asia Network for Chronic Disease- (based in New Delhi, India)

of 24

Asia Pacific Kidney Disease Network (based in Japan)

International Clinical Epidemiology Network (New Delhi, India and Philadelphia)

3:4:50 network for chronic disease (led by UnitedHealth, UK and US)

Duke-NUS/SingHealth Committees & Conferences: 2013-Research Master, Seah College, Duke-NUS

2012-Member, Duke-NUS Medical School Admissions Committee

2012- 3rd Year Medical Student Mentor & Theses Evaluator

2012-SingHelath Grant Review Committee (Clinical)

AKU Committee Memberships: 2009-2010 Member, AKU Dean Search Committee

2008- Co-Chair, AKU Alumni Bylaws Taskforce

2007- 2011 Chair, AKU-Faculty of Health Sciences Research Committee

2007- Member, Advisory Panel, AKU Alumni Affairs

2002- Member, AKU-University Research Council

2002- Member, AKU-Grants Review Committee

2000- Representative, AKU Alumni Association Medical College

International Awards: 2012: International Society of Hypertension Boehringer Ingelheim Developing World Award

National Awards: 2005 Pakistan Academy of Medical Sciences Award for best research paper. 2007- Annual Pakistani Women Achievers on International Women’s Day (March 8)

Other Recognitions: 2011 Fellow of the US National Kidney Foundation

2011 Member of the Henry Wellcome Collection Museum

of 24

Other awards/recognition for Master’s students mentored by Dr Jafar Dr Saleem Jessani’s (MSc) thesis work presented as an oral presentation at the European Society of Hypertension meeting in Milan 2007 Ms Nudrat Qureshi’s (MSc) thesis work presented as an oral presentation at research conference at Singapore. Ms Qureshi awarded the “Merit award” for this work. Ms Qureshi accepted into a funded doctoral program at Cambridge University in computational biology. Dr Zahid Azam (MCR) awarded PGME Research award 2008 by AKU Dr Azra Rizwan (MCR) awarded best oral presentation on MCR thesis project 2009 at Dept of Medicine Research Retreat and won travel award to International Diabetes Federation meeting in Canada Research Grants and Awards: MRC/Wellcome/Dfid UK- S$4.3 million 2015-2018 PI “Primary Care Strategies to Reduce High Blood Pressure- A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka-feasibility study".PI: Tazeen Jafar; Co-PI: Imtiaz Jehan, Asita de Silva, John Clemens; Eric Finkelstein, Preysely Assam) Singapore National Medical Research Council: S$3.4 million 2014-2017 “Management of Hypertension and Multiple Risk Factors in Singapore Polyclinics- A Cluster RCT” . PI Tazeen Jafar (Clinician Scientist Award) Duke Global Health Institute- US $50,000- 2016-2017 PI “Smart-Kidney in rural India”; co-PI Vivek Jha MRC/Wellcome/Dfid UK- $400,000 2014-2015 PI “Integrated Primary Care Strategies to Reduce High Blood Pressure- A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka-feasibility study".PI: Tazeen Jafar; Co-PI: Dewan Alam, Imtiaz Jehan, Asita de Silva, Benjamin Haaland, Eric Finkelstein, Mandy Ow, Shah Ebrahim) Wellcome Trust, UK £ 230,000 (2011-2013) Control of Blood Pressure and Risk Attenuation post-trial follow-up (PI: Tazeen Jafar; Co-PI: Neil Poulter, Juanita Hatcher, Nish Chaturvedi; Shah Ebrahim) Wellcome Trust, UK. £273,032 (2006-2011) Molecular genetic studies in hypertension, type 2 diabetes, and coronary heart disease in Pakistan. (PI: Tim Frayling; Co-PI: Tazeen Jafar/Nish Chaturvedi/Andrew Hattersley/Philippe Frossard/Marc Caulfield)

of 24

Wellcome Trust, UK £ 50,000 (2009) Control of Blood Pressure and Risk Attenuation follow-up (PI: Tazeen Jafar; Co-PI: Juanita Hatcher, Zulfiqar Bhutta, Shah Ebrahim; Nish Chaturvedi) NIH-Fogarty International Center US $ 110,000 (2007-2010) R03 TW007588- “Chronic Kidney Disease in the Pakistani Population-Estimation of Glomerular Filtration Rate” (PI: Tazeen Jafar; Co-PI: Andrew Levey; Christopher Schmid; Lesley Stevens, Nish Chaturvedi; Juanita Hatcher). Wellcome Trust, UK. £273,032 (2006-2011) Molecular genetic studies in hypertension, type 2 diabetes, and coronary heart disease in Pakistan. (PI: Tim Frayling; Co-PI: Tazeen Jafar/Nish Chaturvedi/Andrew Hattersley/Philippe Frossard/Marc Caulfield) Wellcome Trust, UK, 2003-2007. US $500,000 for “Population based strategies for effective control of high blood pressure in Pakistan: (Control of Blood Pressure and Risk Attenuation Trial (COBRA)”. ( PI: Tazeen Jafar; Co-PI: Juanita Hatcher, Neil Poulter, Nish Chaturvedi) Wellcome Trust, UK –2005-2008 US $300,000 for “Hypertension related damage to the microcirculation in South Asians – emergence, predictive power and reversibility. (PI: Nish Chaturvedi; Co-PI Tazeen Jafar) Fogarty International Research Collaboration Award by the Fogarty International Center, NIH, US $ 96,000. May 2002-apr 2007 for “Hypertension in the Pakistani Population-Analysis of the data from the National Health Survey of Pakistan. ( PI: Tazeen Jafar/Andrew Levey; Co-PI Christopher Schmid, Nish Chaturvedi) Cardiovascular Disease Initiative, India, Jan 2005 to June 2005. US $ 10,000. Community strategies for control of tobacco use amongst adolescents in Karachi, Pakistan. (role: PI: Tazeen Jafar) Research award: The Wellcome Trust, UK, 2001-2002, US $150,000 for “The Stepped Care Blood Pressure Control Project” (PI: Tazeen Jafar/Leon Fine; Co PI: Nish Chaturvedi) Paul Teschan Fellowship award by Dialysis Clinic, Inc. (DCI) 1997-1998. US $50,000 for work on Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Renal Disease. (role: PI: Tazeen Jafar; Co-PI Andrew Levey)

Master’s Fellowship Awards for Students with Dr. Jafar as Sponsoring and primary thesis

supervisor

The Wellcome Trust, UK, (ref 069501) 2009-2012, UK £50, 000 for Master’s student fellowship and associated research project on “validation of International physical activity questionnaire with pedometer in children in Pakistan”. Student Dr Shiraz Hashmi

The Wellcome Trust, UK, (ref 069501) 2002-2005, UK £17, 000 for Master’s student fellowship and associated research project on “Knowledge, perceptions, and healthcare seeking behavior in older and younger patients with myocardial infarction in an urban city of Pakistan”. Student Mohammad Saleem

of 24

The Wellcome Trust, UK, (ref: 069502) 2002-2005, UK £20,000 for Master’s student fellowship and associated research project on “Affective and cognitive disease in urban Pakistan”. Student Dr Faiza Habib

Wellcome Trust, UK, (ref: 074825) 2004-2007, UK £40,000 for Master’s student fellowship and associated research project on “Relationship between Salt and Blood Pressure in South Asian Population in Pakistan”. Student Dr Saleem Jessani Wellcome Trust, UK, (ref: 0748440) 2006-2008, UK £47,000 for Master’s student fellowship and associated research project on “Coronary artery disease with thallium-201 scintigraphy in adult population in Karachi”. Student: Dr Shazia Shahzad MD Thesis Supervision: 2012-2014. Domiqiue Seow. Medical Student, Duke-NUS. 2016-2018- Eui Moon, Medical Student, Duke-NUS. MSc Thesis Supervision: Primary thesis supervisor of the following students of Master’s in Epidemiology &

Biostatistics degree Program:

2000-2002. Student: Javed Ismail. Thesis title “Risk factors for nonfatal Myocardial Infarction in young adults of Karachi: Community based case control study.

2002-2004. Student: Muhammed Saleem. Thesis title” Factors associated with delay in seeking health care among those who had Acute Myocardial Infarction.

2002-2005 Student Faiza Habib. Thesis title “Affective and cognitive disease in urban Pakistan”.

2004-2007. Student: Saleem Jessani. Thesis title “Relationship between Salt and Blood Pressure in South Asian Population in Pakistan”.

2004-2007. Student: Nudrat Qureshi. Thesis title “Adherence to antihypertensive medication among patients with hypertension visiting GPs trained in aspects of hypertension detection and management vs untrained GPs 2006-2008 Student: Shazia Shehzad. Thesis title. “Comparison of screening tools for coronary artery disease with thallium-201 scintigraphy in adult population in Karachi”.

of 24

2006-2008 Student Zahid Azam MCR. Thesis title “Randomized double blind dummy controlled trial of 24 versus 72 hours of terlipressin as an adjuvant therapy in esophageal variceal bleed”

2006-2008 Student Aysha Almas MCR. Thesis title: Exercise Intervention in Female School Children; Affect on Blood pressure, BMI, Skinfolds and Maths Scores

2006-2008 Student Azra Rizwan MCR. Thesis title: Factors Associated with Obesity in School children in Karachi

2007-2009- Zainab Hussain MCR Validating Anthropometry for Assessment of Body Fat Composition in 10-14 Year Old Children Using DXA scan as Gold Standard

2007-2009 Sajid Mahmood MSc Thesis title: Prevalence and factors associated with underestimation of body weight among school children of grade 9-10, in Karachi, Pakistan: A school based cross-sectional study 2009-2012, Shiraz Hashmi MSc Thesis title: Validation of International physical activity questionnaire with pedometer in children in Pakistan” Primary thesis supervisor of the following students of Master’s in Global Health degree

Program:

2016-2017: Benjamin Cobb, Duke Global Health Institute

PhD Thesis Supervision: 2009-2012: Nilofer Safdar: Thesis title: “Association of dietary patterns with change in Blood Pressure in South Asian Adults”- Fullbright Scholarship- doctoral student in Nutrition at University of Massachusetts (Primary supervisor is Dr Nancy Cohen at U Mass) Khoo Scholars Supervision: 2015-2017: Jasmine Lew, khoo scholar mentee, Duke-NUS

Published Papers:

of 24

• Jafar TH, Silva A, Naheed A, Jehan I, Liang F, Assam PN, et al. Control of blood pressure

and risk attenuation: a public health intervention in rural Bangladesh, Pakistan, and Sri Lanka: feasibility trial results. Journal of hypertension. 2016;34(9):1872-81. Epub 2016/08/05.

• Jafar TH, Tan NC, Allen JC, Pradhan SS, Goh P, Tavajoh S, et al. Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics. BMC health services research. 2016;16(1):229. Epub 2016/07/09.

• Lew QJ, Jafar TH, Koh HW, Jin A, Chow KY, Yuan JM, et al. Red Meat Intake and Risk of ESRD. Journal of the American Society of Nephrology : JASN. 2016. Epub 2016/07/16.

• Tan RY, Allen JC, Jr., Kee T, Jafar TH. Predictors of low estimated glomerular filtration

rate after living kidney donation in a Southeast Asian population from Singapore. Nephrology (Carlton). 2016. Epub 2016/06/29.

• • Jafar TH, Allen JC, Jehan I, Hameed A, Saffari SE, Ebrahim S, Poulter N, Chaturvedi N.

Control of Blood Pressure and Risk Attenuation: Long Term Effects on Kidney Function. cJASN (in press- online May 19, 2016)

• Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic Kidney Disease in Low and Middle Income Countries. Nephrology Dialysis Transplantation April 2016

• Jafar TH, Jehan I, Liang F, Barbier S, Islam M, Bux R, et al. Control of Blood Pressure and

Risk Attenuation: Post Trial Follow-Up of Randomized Groups. PLoS One. 2015;10(11):e0140550.

• Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular

filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514-25. [citations 23]

H-index 41 I-10 57

of 24

• Jafar TH, Assam PN. Dual RAAS blockade for kidney failure: hope for the future. Lancet.

2015;385(9982):2018-20.

• Seow DY, Haaland B, Jafar TH. The Association of Prehypertension With Meals Eaten Away From Home in Young Adults in Singapore. Am J Hypertens. 2015;28(10):1197-200.

• Coresh J, Jafar TH. Disparities in worldwide treatment of kidney failure. Lancet. 2015;385(9981):1926-8.

• Jafar TH, Jin A, Koh WP, Yuan JM, Chow KY. Physical activity and risk of end-stage

kidney disease in the singapore chinese health study. Nephrology (Carlton). 2015;20:61-67

• Jessani S, Jafar TH. In reply to 'validating gfr estimating samples with clinical outcomes'. American journal of kidney diseases :2014;63:859-860

• Jessani S, Levey AS, Bux R, Inker LA, Islam M, Chaturvedi N, Mariat C, Schmid CH, Jafar TH. Estimation of gfr in south asians: A study from the general population in pakistan. American journal of kidney diseases : 2014;63:49-58

• Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney

disease in karachi, pakistan - a community based cross-sectional study. BMC nephrology. 2014;15:90

• Jafar TH, Jin A, Koh WP, Yuan JM, Chow KY. Physical activity and risk of end stage

kidney disease in the singapore chinese health study. Nephrology (Carlton). 2014

• Islam M, Jafar TH, Bux R, Hashmi S, Chaturvedi N, Hughes AD. Association of parental blood pressure with retinal microcirculatory abnormalities indicative of endothelial dysfunction in children. Journal of Hypertension. 2014;32:598-605

• Gee ME, Campbell N, Sarrafzadegan N, Jafar T, Khalsa TK, Mangat B, Poulter N, Prabhakaran D, Sonkodi S, Whelton PK, Woodward M, Zhang XH. Standards for the uniform reporting of hypertension in adults using population survey data: Recommendations from the world hypertension league expert committee. J Clin Hypertens (Greenwich). 2014;16:773-781

• Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman

GW, Muntner P, Roderick P, Sairenchi T, Schottker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Arnlov J. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data. The lancet. Diabetes & endocrinology. 2015;3:514-525

of 24

• Jafar TH, Assam PN. Dual raas blockade for kidney failure: Hope for the future. Lancet. 2015;385:2018-2020

• Seow DY, Haaland B, Jafar TH. The association of prehypertension with meals eaten away

from home in young adults in singapore. American journal of hypertension. 2015;28:1197-1200

• Coresh J, Jafar TH. Disparities in worldwide treatment of kidney failure. Lancet.

2015;385:1926-1928

• Jafar TH, Haaland BA, Rahman A, Razzak JA, Bilger M, Naghavi M, Mokdad AH, Hyder AA. Non-communicable diseases and injuries in Pakistan: Strategic priorities. Lancet. 2013;381:2281-2290 [citations 26]

• Nishtar S, Bhutta ZA, Jafar TH, Ghaffar A, Akhtar T, Bengali K, Isa QA, Rahim E. Health reform in Pakistan: A call to action. Lancet. 2013;381:2291-2297 [citations 25]

• Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet. 2013;382:339-352 [citations 252]

• Jessani S, Levey AS, Bux R, Inker LA, Islam M, Chaturvedi N, Mariat C, Schmid CH, Jafar TH. Estimation of GFR in south asians: A study from the general population in pakistan. American journal of kidney diseases 2013

• Jin A, Koh WP, Chow KY, Yuan JM, Jafar TH. Smoking and risk of kidney failure in the singapore chinese health study. PloS one. 2013;8:e62962

• Almas A, Islam M, Jafar TH. School based physical activity program in pre-adolescent girls

(9-11 years) A feasibility trial in Karachi, Pakistan. Arch Dis Child (in press) • Jafar TH, Agarwal S. A Decade After the KDOQI CKD Guidelines: A Perspective from South Asia. American Journal of Kidney Diseases 2012 Nov;60(5):731-3.

• Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for

estimated glomerular filtration rate. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium. JAMA. 2012 May 9;307(18):1941-51 [citations 30]

of 24

• Islam M, Jafar TH, Wood AR, De Silva NM, Caulfield M, Chaturvedi N, Frayling TM. Multiple genetic variants explain measurable variance in type 2 diabetes- related traits in Pakistanis. Diabetologia. 2012

• Jafar TH, Islam M, Bux R, Poulter N, Hatcher J, Chaturvedi N, Ebrahim S, Cosgrove P. Cost

Effectiveness of Community Based Strategies for Blood Pressure Control in a Low income Developing Country: Findings from A Cluster Randomized Factorial Controlled Trial. Circulation. Nov 2011 [citations 35]

• Jafar TH, Islam M, Jessani, S, Bux R, Stevens, LA, Mariat, C, Levey, AS. Level and Determinants of Kidney Function in a South Asian Population in Pakistan. American Journal of Kidney Diseases Oct 2011

• Faqah A, Jafar TH. Control of Blood Pressure in Chronic Kidney Disease-How Low to

Go? Nephron Clinical Practice Nov 2011 • Jessani S, Levey AS, Chaturvedi N, Jafar TH. The Association of High Normal Levels

of Albuminuria with Incident Hypertension in Indo-Asian Population. Nephrol Dial Transplant May 2011

• Almas A, Jafar TH. Adiposity and Blood Pressure in South Asian Children

and Adolescents in Karachi. Am J Hypertension. April 2011 • Rees S, Islam M, Hydrie MZ, Chaudhary B, Bellary SB, Hashmi S, O’ Hare JB, Kumar S,

Sanghers DK, Chaturvedi N, Barnett AH, Shera AS, Weedon M, Basit A, Frayling T, Kelly MA, Jafar TH. FTO variants are associated with Type 2 Diabetes in South Asian Populations after accounting for Body Mass Index and Waist Circumference. Diabetic Medicine 2011 Feb 5. [citations 55]

• Rizwan A, Akhter J, Jafar TH. The association of sugar-sweetened beverage consumption and inadequate physical activity with overweight and obesity in school-going children and adolescents in Pakistan. Arch Dis Child. 2010 Sep 18

• Jafar TH, Islam M, Hatcher J, Hashmi S, Bux R, Khan A, Poulter N, Badruddin S,

Chaturvedi N; Hypertension Research Group. Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial. BMJ. 2010 Jun 7;340:c2641. [citations 90]

• Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, et al. Community-based

interventions to promote blood pressure control in a developing country: a cluster

of 24

randomized trial Ann Intern Med Ann Intern Med. 2009 Nov 3;151(9):593-601 [citations 86]

• Tazeen H Jafar, Zeeshan Qadri, Shiraz Hashmi. Prevalence of microalbuminuria and associated electrocardiographic abnormalities in an Indo-Asian population. Nephrol Dial Transplant 2009.

• Fahim Jafary, Tazeen H. Jafar Disproportionately high risk of left ventricular hypertrophy in Indo-Asian women: a call for more studies. Echocardiography 2008 Sep;25(8):812-9

• Jessani S, Hatcher J, Chaturvedi N, Jafar TH. Effect of low vs. high dietary sodium on blood pressure levels in a normotensive Indo-Asian population. Am J Hypertens. 2008 Nov;21(11):1238-44 [citations 9]

• Qureshi NN, Hatcher J, Chaturvedi N, Jafar TH; Hypertension Research Group. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ. 2007 Nov 17;335(7628):1030. [citations 71]

• Tazeen H Jafar , Zeeshan Qadri,Mohammad Islam, Juanita Hatcher, Zulfiqar A Bhutta, Nish Chaturvedi. Rise in childhood obesity with persistently high rates of undernutrition among urban school-aged Indo-Asian children. Arch Dis Child. 2008 May;93(5):373-8.

• Tazeen H. Jafar, Zeeshan Qadri, Nish Chaturvedi. Coronary Artery Disease Epidemic In

Pakistan-Women and Men at Equal Risk. Heart. 2008 Apr;94(4):408-13. Citations 146

• David M Kent, Tazeen H Jafar, Rodney A Hayward, Hocine Tighiouart, Marcia Landa, Paul de Jong, Dick de Zeeuw, Giuseppe Remuzzi, Anne-Lise Kamper, and Andrew S Levey . “Progression Risk, Urinary Protein Excretion and the Treatment Effects of Angiotensin Converting Enzyme Inhibitors in Non-Diabetic Kidney Disease. Journal of the American Society of Nephrology 2007 Jun;18(6):1959-65. [Citations 123]

• Tazeen H. Jafar, Nish Chaturvedi, Juanita Hatcher, Andrew S Levey. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. Nephrol Dial Transplant. 2007 Apr 3; [citations 62]

• Tazeen H. Jafar, Nish Chaturvedi, Gregory Pappas. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. Canadian Medical Association Journal. 2006 Oct 24;175(9):1071-7. [citations 252]

of 24

• Tazeen H. Jafar. Hypertension and Kidney Disease in Asia. Current Opinion in Nephrology and Hypertension 2006 May;15(3):291-5.

• Muhammad S Khan, Fahim H Jafary, Tazeen H Jafar, Azhar M Faruqui, Syed I Rasool, Juanita Hatcher, Nish Chaturvedi Knowledge of modifiable risk factors of heart disease among patients with acute myocardial infarction in Karachi, Pakistan: a cross sectional study. BMC Cardiovascular 2006 Apr 27;6:18. [citations 65]

• Munira M. Shahpurwala, Nadia Sani, Shehzad Shah, Fahad Shuja, Kamran Shahid, Hamza Tariq, Zohra Huda, Lubna Zuberi, and Tazeen H Jafar. General Medical Practitioners in Pakistan fail to adequately educate patients about complications of diabetes. Practical Diabetes International Mar 2006.

• Tazeen H. Jafar. Blood pressure, Diabetes, and Increased Dietary Salt Associated with Stroke-Results form a Community Based Study in Pakistan. Journal of Human Hypertension 2006 Jan;20(1):83-85. [citations 58]

• Khabir Ahmad, Tazeen H. Jafar. Prevalence and determinants of blood pressure screening in Pakistan. Journal of Hypertension 2005 Nov;23(11):1979-84.

• Tazeen H. Jafar. Women In South Asia Have A Greater Burden of Clinical Cardiovascular Risk Factors Than Men. International Journal of Cardiology. 2006 Jan 26;106(3):348-54

• Tazeen H. Jafar, Saleem Jessani, Fahim H. Jafary, Mohammad Ishaq, Raza Orkazai, Sarwar Orkazai, Andrew S. Levey, and Nish Chaturvedi. General Practitioners’ Approach to Hypertension in Urban Pakistan-Disturbing Trends in Practice. Circulation 2005;111:1278-83. [citations 82]

• Tazeen H. Jafar, Muhammad Islam, Neil Poulter, Juanita Hatcher, Christopher H. Schmid, Andrew S. Levey, and Nish Chaturvedi. Children In South Asia Have Higher Body Mass Adjusted Blood Pressure Levels Than Caucasian Children In The United States -A Comparative Study. Circulation 2005;111:1291-7. [citations 131]

• Tazeen H Jafar, Christopher H. Schmid, and Andrew S. Levey. Serum Creatinine As Marker Of Renal Function In South Asians: A Study Of Reduced Glomerular Filtration Rate In Adults In Pakistan. Journal of the American Society of Nephrology 2005;16:1413-9. [citations 115]

• Tazeen H Jafar, Fahim H. Jafary, Saleem Jessani, and Nish Chaturvedi. Heart Disease Epidemic in Pakistan: Women and men at equal risk. American Heart Journal 2005;150:221-6. [citations 146]

• Tazeen H. Jafar, Nish Chaturvedi, Juanita Hatcher, Iqtidar Khan, Anas Rabbani, Abdul Qayum Khan, Ronald Portman, Christopher H. Schmid , and Andrew S. Levey.

of 24

Proteinuria in South Asian children: prevalence and determinants. Pediatric Nephrology 2005.

• Khabir Ahmad, Tazeen H. Jafar, Chaturvedi N. Self-rated health in Pakistan: results of a national health survey. BMC Public Health. 2005;5:51. [citations 55]

• Tazeen H. Jafar. Systemic Hypertension and Nondiabetic Chronic Kidney Disease: The Best Evidence-Based Therapeutic Approach Today. European Review for Medical and Pharmacological Sciences 2005;9:1-12.

• Khabir Ahmad, Fahim Jafary, Imtiaz Jehan, Juanita Hatcher, Abdul Qayum, Nish Chaturvedi, Tazeen H Jafar. Prevalence and predictors of smoking in Pakistan: Results of the National Health Survey of Pakistan. European Journal of Cardiovascular Prevention and Rehabilitation 2005;12:203-8. [citations 82]

• Tazeen H Jafar, Paul C. Stark, Christopher H Schmid, Svend Strandgaard, Anne-Lise Kamper, Giuseppe Maschio, Gavin Becker, Ronald D. Perrone, and Andrew S Levey, for the ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group. The Effect Of Angiotensin-Converting-Enzyme Inhibitors On Progression Of Advanced Polycystic Kidney Disease. Kidney International 2005;67(1):265-71. [citations 86]

• Jafar TH, Levey AS, White FM, Gul A, Jessani S, Khan AQ, Jafary FH, Schmid CH, Chaturvedi N. Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan. Diabet Med. 2004 Jul;21(7):716-23. [citations 59]

• J Ismail, T H Jafar, F H Jafary, F White, A M Faruqui, and N Chaturvedi. Risk factors for non-fatal myocardial infarction in young South Asian adults Heart, 2004; 90: 259 - 263. [citations 156]

• Tazeen H Jafar, Paul C. Stark, Christopher H Schmid, Marcia Landa, Giuseppe Maschio, Paul E de Jong, Dick de Zeeuw, Shahnaz Shahinfar, Robert Toto, and Andrew S Levey for the AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003 Aug 19;139(4):244-52. [949 citations]

*Editorial by Cynthia D. Mulrow and Raymond R. Townsend. Guiding Lights for Antihypertensive Treatment in Patients with Nondiabetic Chronic Renal Disease: Proteinuria and Blood Pressure Levels? 2003 Aug 19;139(4): 296-198.

• Tazeen H Jafar, Andrew S Levey, Franklin White, Fahim H. Jafary, Asma Gul, Mohammad H. Rahbar , Abdul Q Khan, Andrew Hattersley, Christopher H. Schmid, and Nish Chaturvedi. Ethnic Subgroup Differences in Hypertension in Pakistan. Journal of Hypertension 2003 May;21(5):905-912. [Citations 141]

of 24

• Christopher H Schmid, Marcia Landa, Tazeen H Jafar, Ioannis Giatras, Tauqeer Karim, Manoj Reddy, Paul C Stark, and Andrew S Levey for the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Disease (AIPRD) Study Group. Constructing a Database of Individual Clinical Trials for Longitudinal Analysis. Controlled Clinical Trials. 2003 Jun;24(3):324-40. [citations 21]

• TH Jafar, CH Schmid, R Toto, PE de Jong, G Remuzzi, P Ruggenenti, A Perna, P Zuchelli, A Himmelmann, G Maschio, C Marcantoni, and AS Levey, for the AIPRD Study Group. ACE inhibitors retard renal progression in both genders. Nephrology Dialysis Transplantation 2003 Oct;18(10):2047-53 [citations 83]

• Tazeen H Jafar, Nish Chaturvedi, Asma Gul, Abdul Q Khan, Christopher H. Schmid, and Andrew S. Levey. Ethnic Differences and Determinants Of Proteinuria Among South Asian Subgroups In Pakistan. Kidney International 2003 Oct;64(4):1437-44.

• T.H. Jafar, C.H.Schmid, M. Landa, I. Giatras, R. Toto, G. Remuzzi, G. Maschio, B.M.Brenner, A. Kamper, P. Zucchelli, G. Becker, A. Himmelmann, K. Bannister, P. Landais, S. Shahinfar, P.E. de Jong, D. de Zeeuw, J. Lau, A.S. Levey, for the AIPRD Study Group. The Role of Angiotensin Converting Enzyme Inhibitors in Non-Diabetic Renal Disease..A Meta-Analysis of Patient-Level Data. Annals of Internal Medicine vol 135(2) pg 73-87 July 17, 2001.* [944 citations]

*Review on the above article: Angiotensin-converting enzyme inhibitors reduce the

progression of nondiabetic renal disease. ACP Journal Club/Evidence-Based Medicine Jan/Feb 2002, page 12.

• Tazeen H Jafar, Christopher H Schmid, Marcia Landa, Paul Stark, Guisseppe Maschio,

Carmelita Marcantoni, Paul E de Jong, Dick de Zeeuw, Shahnaz Shahinfar, Pierro Ruggenenti, G Remuzzi and Andrew S Levey, for the AIPRD Study Group. Proteinuria as a Modifiable Risk Factor for the Progression of Non-Diabetic Renal Disease. Kidney International 2001. ; 60(3): 1131-1140. [369 citations]

• C. Marcantoni, TH Jafar, L Oldrizzi, AS Levey, G Maschio, The role of systemic hypertension in the progression of nondiabetic renal disease. Kidney International 2000; 57 Suppl 75 pp 44-8. [citations 43]

• TH Jafar, BJP Pereira. A Cautionary Note to Nephrologists: Should the use of dihydropyridine calcium channel blockers be abandoned? Seminars in Dialysis, May-June 1999, vol 12 no. 3, pg 137-139.

Commissioned Editorials/ Commentaries:

of 24

• Jafar TH Commentary: Cardiovascular risk factors--the next epidemic in Uganda: findings from the population-based HIV/AIDS rural surveillance cohort. Int J Epidemiol. 2010 Oct 29.

• Tazeen H Jafar. World Kidney Forum. Organ Trafficking: Global Solutions for a Global Problem. American Journal of Kidney Diseases 2009 Dec;54(6):1145-57 [citations 41]

• Jafar TH. Children, obesity, and high blood pressure: Asian populations at high risk. Am J Hypertens. 2009 Jan;22(1):6-7.

• Jafar TH, Ebrahim SB. Variations in levels of blood pressure: of prognostic value or not? American Journal of Kidney Diseases 2008 Oct;52(4):638-41

• Tazeen H. Jafar. Growing Burden of Chronic Kidney Disease in Pakistan. New England Journal of Medicine 2006; Mar; 354 (10): 995-7. [citations 65]

• Tazeen H. Jafar. 71% of patients with newly diagnosed chronic kidney disease progressed to renal replacement therapy or death within 3 years. Evid Based Med. 2006 Aug;11(4):118.

• Tazeen H. Jafar, Modified MDRD equations outperform the original equations in Chinese patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007 Apr;3(4):186-7. Epub 2007 Feb 13.

Letters:

• Tazeen H Jafar , Juanita Hatcher , Zulfiqar A Bhutta. Rapidly rising rates of overweight and obesity coupled with persistently high rates of undernutrition among school aged children in an urban Indo-Asian population: authors' response. Arch Dis Child. 2008 Nov;93(11):1000-1.

• T.H. Jafar, C.H.Schmid, Levey AS. Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. Annals of Internal Medicine. 2002 Aug 20;137(4):298-9.

Consortia Publications:

of 24

• ICBPGWAS. Genetic variants in novel pathways Influence Blood Pressure and Cardiovascular Disease Risk. Nature (in press)

• Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011 Jul 2;378(9785):31-40.

• Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, Musani SK, Liu K, Morrison AC, Ganesh S, Kutlar A, Ramachandran VS, Polak JF, Fabsitz RR, Dries DL, Farlow DN, Redline S, Adeyemo A, Hirschorn JN, Sun YV, Wyatt SB, Penman AD, Palmas W, Rotter JI, Townsend RR, Doumatey AP, Tayo BO, Mosley TH Jr, Lyon HN, Kang SJ, Rotimi CN, Cooper RS, Franceschini N, Curb JD, Martin LW, Eaton CB, Kardia SL, Taylor HA, Caulfield MJ, Ehret GB, Johnson T; The International Consortium for Blood Pressure Genome-wide Association Studies (ICBP-GWAS); CARDIoGRAM consortium; CKDGen consortium; KidneyGen consortium; EchoGen consortium; CHARGE-HF consortium, Chakravarti A, Zhu X, Levy D. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet. 2011 Apr 8

• Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM,

Lin JK, Stevens GA, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol). National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet. 2011 Feb 12;377(9765):578-86. Epub 2011 Feb 3

• Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011 Feb 12;377(9765):557-67. Epub 2011 Feb 3

• Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health

of 24

examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011 Feb 12;377(9765):568-77. Epub 2011 Feb 3

• CKD Prognosis Consortium Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010 Jun 12;375(9731):2073-81. Epub 2010 May 17

Book Chapters: 1. Tazeen H. Jafar and Aamir Hammed. Proteinuria In Hypertension – Implications For

Prognosis And Therapy. Advanced Therapy in Hypertension and Vascular Disease. Editors: Mohler/Townsend BC Decker Inc, Ontario, Canada. 2006.

2. Tazeen H Jafar. “The Role of Proteinuria in management of Hypertension. The Year in Hypertension (seventh volume). Mohler/Townsend BC Decker Inc, Ontario, Canada. 2007. 3. Absar Ali, Quratulain Khan, Tazeen H. Jafar. Kidney Stones and Chronic Kidney Disease. Urolithiasis -- Basic Science And Clinical Practice. Editors: Talati/Tiselius/Albala/Ye. Springer. London. 2012

curriculum vitae tazeen h. jafar, mbbs; mph personal details · curriculum vitae tazeen h. jafar,...

Documents